[CYCC] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -77.54%
YoY- -21.48%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 373 0 0 0 0 0 0 -
PBT -6,034 -5,559 -6,091 -2,452 -2,090 -2,354 -2,455 16.16%
Tax -586 -984 -964 -286 -307 -502 -268 13.92%
NP -5,448 -4,575 -5,127 -2,166 -1,783 -1,852 -2,187 16.42%
Tax Rate - - - - - - - -
Total Cost 5,821 4,575 5,127 2,166 1,783 1,852 2,187 17.71%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -1,460.59 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -6.51 -0.45 -0.56 -0.56 -2.07 -3.09 -9.86 -6.68%
EPS Diluted -6.51 -0.45 -0.56 -0.56 -2.07 -3.09 -9.86 -6.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.